BX-U007

N/A

Report date: 2023/01/12 15:31:57

Base Information

Drug NameBX-U007
Drug Alias NameBX-U007
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCerebral Palsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBaylx Inc
Inactive CompaniesN/A
Active IndicationsCerebral Palsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A